Barely Significant
← all excerpts

Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial.

Obstet Gynecol Sci · 2020 · PMC7073356 · PMID 32206660

2
hedged sentences
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

trending toward significanceP <0.05actually significant
Compared with placebo (rather than baseline) depression, perceived stress and general anxiety were significantly improved with oxaloacetate/vitamin C treatment, with aggression trending toward significance ( P <0.05, P <0.05, P <0.05 and P =0.060, respectively).

also in 580 other papers

highly significantno p-value reported
All results were highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.